Alkem Laboratories received Form 483 with seven observations after US FDA inspection at its Amaliya, Daman facility.
The inspection was conducted from April 20, 2026 to May 1, 2026 at the company's manufacturing plant.
Company committed to address all observations within the stipulated timeframe as per regulatory requirements.
Regulatory filing submitted to BSE and NSE regarding this material compliance development.